Market research
603963.SHG Dali Pharmaceutical Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 259M
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.08
Community
Investor discussion
1 comment
Sign in to join the 603963.SHG discussion.
5 years, 5 months ago
Dali Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 4.5% below its 200 day moving average.
From a valuation standpoint, the stock is 24.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.3.
Dali Pharmaceutical Co., Ltd's total revenue sank by 15.0% to $58M since the same quarter in the previous year.
Its net income has increased by 72.5% to $4M since the same quarter in the previous year.
Finally, its free cash flow grew by 78.6% to $-4M since the same quarter in the previous year.
Based on the above factors, Dali Pharmaceutical Co., Ltd gets an overall score of 3/5.